NOX4通过促进神经元铁亡和神经炎症来加剧帕金森病的病理学
Zhihao Lin1, Changzhou Ying, Xiaoli Si
1Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Neural regeneration research
|July 12, 2024
概括
通过增加氧化应激,NADPH氧化酶4在帕金森病模型中促进铁和神经炎症. 抑制NADPH氧化酶4可以保护多巴胺能神经元,并提供一种潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 帕金森病 (PD) 的特点是黑色物质中多巴胺基神经元的损失.
- 铁,一种涉及铁和脂质过氧化的受调细胞死亡形式,有助于这种神经元损失.
- 在PD中驱动铁亡的精确机制,特别是NADPH氧化酶4的作用,尚未完全理解.
研究的目的:
- 在PD模型中研究NADPH氧化酶4在多巴胺基神经元的铁化中的参与.
- 阐明 NADPH 氧化酶 4 影响铁和神经炎症的潜在分子机制.
主要方法:
- 使用了一种由1-甲基-4--1,2,3,6-四胺 (MPTP) 诱导的帕金森病小鼠模型.
- 评估了NADPH氧化酶4及其调节剂 (激活转录因子3) 的表达.
- 评估了NADPH氧化酶4抑制对多巴胺基神经元存活,铁亡标志物 (脂质过氧化,铁积累),行为缺陷和神经炎症 (利波卡林-2) 的影响.
主要成果:
- 在MPTP模型中,激活转录因子3提高了多巴胺基神经元和星球细胞中NADPH氧化酶4的表达.
- 抑制NADPH氧化酶4改善了行为障碍,减少了多巴胺基神经元死亡,并在黑色物质中减少了ferroptosis标志物.
- 抑制NADPH氧化酶4还降低了天体细胞的利波卡林-2,减轻了MPTP诱导的神经炎症.
结论:
- NADPH氧化酶4促进铁和神经炎症,有助于帕金森病中多巴胺基神经元死亡.
- NADPH氧化酶4与活性蛋白激酶C α相互作用,以调节铁.
- NADPH氧化酶4代表了帕金森病治疗的有前途的治疗标.
更多相关视频
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.5K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.5K
相关概念视频
01:15Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522
01:24Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
01:37Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
01:16Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K